Home
 Search
 Category
 Compounds
 Status
 Download
 Contacts
 Resources


Compound category: Benzene and substituted derivatives
(total 24 related compounds in database, current show from 1 to 10)
 
Compound name 2D structure Target pathogen(s) Related VF/VFcategory Max phase Reference(s)
2-Fluoro-6-(trifluoromethyl)benzoic acid Depiction based on curated SMILES F O HO F F F Yersinia TTSS secreted effectors Preclinical (in vivo) Liang F, et al. 2003. J Biol Chem
4-Iodobenzoic acid Depiction based on curated SMILES O HO I Yersinia TTSS secreted effectors Preclinical (in vivo) Liang F, et al. 2003. J Biol Chem
Aurintricarboxylic acid Depiction based on curated SMILES O OH OH O OH O OH HO O Yersinia TTSS secreted effectors Preclinical (in vivo) Liang F, et al. 2003. J Biol Chem
6-[(4-nitrobenzoyl)amino]hexanoic Acid Depiction based on curated SMILES O _ O O + N O HN OH Yersinia TTSS secreted effectors Preclinical (in vivo) Liang F, et al. 2003. J Biol Chem
Chrome Azurol S Depiction based on curated SMILES O OH CH 3 Cl S O O OH Cl O HO H 3 C OH O Yersinia TTSS secreted effectors Preclinical (in vivo) Liang F, et al. 2003. J Biol Chem
Imidocarb Depiction based on curated SMILES O NH N NH N H NH N Escherichia
Yersinia		 TTSS (Type III secretion system)
TTSS (Type III secretion system)		 Preclinical (in vitro)
Preclinical (in vitro)		 Pan NJ, et al. 2009. Antimicrob Agents Chemother
N-(1,3-dimethyl-2-oxo-6-pyrrolidin-1-yl-2,3-dihydro-1H-benzimidazol-5-yl)-N'-(3,4-dimethylphenyl)urea Depiction based on curated SMILES CH 3 CH 3 N O H 3 C N N CH 3 N H O N H Yersinia TTSS (Type III secretion system) Preclinical (in vitro) Harmon DE, et al. 2010. Antimicrob Agents Chemother
1-{4-[(2-nitrophenyl)sulfonyl]piperazin-1-yl}-2-phenoxyethanone Depiction based on curated SMILES S _ O O + N O O O N N O Yersinia TTSS secreted effectors Preclinical (in vitro) Hu X, et al. 2013. Bioorg Med Chem Lett
2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-5-chloro-N-(3,4-dichlorophenyl)benzamide Depiction based on curated SMILES Cl Cl N H O Cl N H O O S N S N Yersinia TTSS (Type III secretion system) Preclinical (in vitro) Kauppi AM, et al. 2003. Chem Biol
2-chloro-4-{5-[(E)-2-(4,6-dihydroxy-5-nitropyrimidin-2-yl)ethenyl]furan-2-yl}benzoic acid Depiction based on curated SMILES O NH O _ O O + N HO N O Cl OH Yersinia TTSS secreted effectors Preclinical (in vitro) Eriksson J, et al. 2012. Adv Exp Med Biol
   


NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.



Page  1  2  3 



Back to top
2004-2024 NIPB, CAMS&PUMC